2,4-Dibormothiazole

2,4‑Dibromothiazole is employed as the sole source of a 2,4‑disubstituted thiazole pharmacophore in agrichemical discovery programs targeting succinate dehydrogenase (SDH). In a representative kilogram‑scale synthesis of a 2‑aryl‑4‑(anilino)thiazole fungicide precursor, the C‑2 bromine is chemo‑selectively coupled with 3‑(difluoromethyl)‑1‑methyl‑1H‑pyrazole‑4‑boronic acid (1.05 equiv) using Pd(dppf)Cl₂·CH₂Cl₂ at 2 mol% loading and K₃PO₄ (2.5 equiv) in a degassed 1,4‑dioxane/water mixture (3:1 v/v). The reaction proceeds in a 200 L glass‑lined reactor equipped with a retreat‑blade impeller and a Lauda Integral T process thermostat maintaining 85 °C ± 1 °C for 6 h; >97% regioselectivity is confirmed by sampling through an inline Agilent 7890B/5977A GC‑MS with a DB‑5MS capillary column. After cooling, the crude 2‑(1‑methyl‑3‑difluoromethylpyrazol‑4‑yl)‑4‑bromothiazole is precipitated into deionised water, filtered on a Nutsche filter, and recrystallised from methanol to afford a crystalline intermediate with a purity of 99.2 area% by HPLC (Waters XBridge C18, 5 µm, 4.6×250 mm; 70:30 acetonitrile/water; 254 nm; retention time 8.3 min). The residual 4‑bromo substituent is then displaced via a CuI‑mediated C–N coupling with 2‑fluoro‑4‑(trifluoromethyl)aniline (1.2 equiv) and N,N′‑dimethylethylenediamine (20 mol%) in dry DMF at 110 °C for 14 h under nitrogen. The resultant active ingredient, isolated as a white crystalline solid with a melting range of 172–174 °C, is formulated as a 500 g/L suspension concentrate after milling on a Netzsch MiniCer bead mill to a particle size of d₉₀ < 2.5 µm (Malvern Mastersizer 3000). Regulatory compliance for the SC formulation relies on CIPAC Method MT 184 for suspensibility and OECD 509 field residue decline studies; LC‑MS/MS analysis (ESI+, MRM transition m/z 407 → 215) achieves an LOQ of 0.01 mg/kg in cereal grain matrices, fulfilling EU Regulation 396/2005 MRL data requirements. The foliar‑applied product is targeted at 75–150 g a.i./ha for Septoria tritici control, with the thiazole ring serving as the critical hydrogen‑bond acceptor in the SDH ubiquinone‑binding pocket.

Why Differential Halogen Reactivity Drives Process Economics in API Manufacturing

In active pharmaceutical ingredient supply chains, the sequence in which the two bromine atoms of 2,4‑dibromothiazole participate in palladium‑mediated cross‑couplings determines both the overall yield and the viability of a catalytic asymmetric route. The electron‑deficient nature of the thiazole nucleus renders the C‑2 position susceptible to oxidative addition with Pd(0) complexes at a rate considerably faster than that at C‑4. This kinetic differentiation has been quantified under identical model conditions—THF/H₂O (4:1 v/v), K₂CO₃ (2.0 equiv), 60 °C, phenylboronic acid (1.0 equiv)—with the selectivity factor k_C‑2/k_C‑4 spanning more than an order of magnitude depending on the ancillary ligand. A comparative screening table compiled from batch reactor campaign data is shown below.

The pronounced selectivity attainable with the PEPPSI‑IPr precatalyst allows a factory to execute the first C‑2 coupling without protecting the C‑4 site, eliminating two unit operations compared to a protection‑deprotection route. In a campaign producing a key intermediate for an ATP‑competitive kinase inhibitor, the process was transferred from batch to a coiled‑tube continuous‑flow reactor to manage the exothermic oxidative addition event. The flow rig consisted of a 1.0 mm I.D. PFA coil (internal volume 10 mL) fed by a Knauer Azura P4.1S dual‑piston pump, with a residence time of 45 s at 75 °C back‑pressured to 3.5 bar with a Zaiput membrane back‑pressure regulator. Under these conditions, 98.5% conversion of the 2‑bromothiazole was achieved with <0.3% dimerisation by‑product, a value unattainable in the batch regime due to localised hot spots. The 4‑bromo intermediate was isolated continuously through a liquid–liquid extraction module and telescoped into a second Suzuki coupling with a boronate ester derived from a 5‑quinolinyl fragment using Pd(dppf)Cl₂ (1 mol%) at 95 °C. The final API intermediate, after a charcoal treatment to adsorb residual palladium to <10 ppm, complied with ICH Q3D elemental impurity limits and was released with 99.4 area% purity by UPLC‑UV (215 nm). Residual solvent levels met ICH Q3C options for 1,4‑dioxane (Class II; limit 380 ppm) and DMF (Class II; limit 880 ppm), confirmed by headspace GC‑FID. The ability to purchase a single heterocyclic dihalide and differentiate its reaction sites through ligand‑controlled catalysis reduces the structural complexity of building blocks in medicinal chemistry libraries while maintaining the flexibility to introduce pharmacophoric vectors at both the 2‑ and 4‑positions of the thiazole ring, a feature leveraged in the synthesis of clinical candidates acting on the p38α MAP kinase and CFTR gating domains.

Donor–Acceptor Copolymer Backbone Engineering via Stille Polycondensation

2,4‑Dibromothiazole functions as the electron‑deficient comonomer in the synthesis of push‑pull π‑conjugated polymers used as the photoactive layer in organic photovoltaic (OPV) cells. In a representative donor–acceptor copolymerisation, the dibromothiazole is copolymerised with a distannylated benzodithiophene derivative—2,6‑bis(trimethyltin)‑4,8‑bis(2‑ethylhexyloxy)benzo[1,2‑b:4,5‑b′]dithiophene—using a Stille coupling protocol. The molar feed ratio of the dibromo monomer to the distannyl monomer must be controlled to within ±0.5 mol% of unity to achieve a number‑average molecular weight (Mₙ) exceeding 25 kDa; deviations of 1 mol% from stoichiometric balance cause Mₙ to collapse below 8 kDa, as predicted by the Carothers equation and confirmed by GPC‑PS calibration. Both monomers are purified by repetitive recrystallisation and sublimation, and their exact masses are verified by ¹H NMR end‑group analysis with an internal standard prior to charging the reaction tube. The polymerisation is conducted in a 50 mL pressure‑rated Schlenk tube with a Teflon screw‑cap, loaded inside an argon‑atmosphere glovebox (O₂ <0.5 ppm, H₂O <0.5 ppm) with the two monomers, Pd₂(dba)₃ (2 mol%) and P(o‑tolyl)₃ (16 mol%), in anhydrous chlorobenzene/DMF (9:1 v/v). The sealed vessel is heated in a Biotage Initiator microwave reactor at 140 °C for 45 min, followed by an end‑capping sequence with 2‑tributylstannylthiophene and 2‑bromothiophene (2 equiv each, 20 min additional heating) to eliminate reactive chain ends. After precipitation into methanol, the crude polymer is subjected to sequential Soxhlet extraction with methanol, acetone, and hexane, and the final chloroform fraction is collected and dried under vacuum, yielding a shiny dark‑blue film‑forming material with Mₙ 38.3 kDa, PDI 2.1. Inverted device architecture ITO/ZnO/polymer:PC₇₁BM/MoO₃/Ag fabricated by doctor‑blading in a nitrogen‑filled MBraun glovebox and tested under AM1.5G 100 mW/cm² illumination (ASTM E1021‑15) typically produces a short‑circuit current density of 14.2 mA/cm², an open‑circuit voltage of 0.82 V, and a fill factor of 0.67, resulting in a power conversion efficiency of 7.8%. The thiazole ring’s strong electron‑withdrawing character lowers the lowest unoccupied molecular orbital (LUMO) level to ‑3.75 eV as measured by cyclic voltammetry (ferrocene internal standard, 0.1 M Bu₄NPF₆ in acetonitrile, scan rate 50 mV/s), which provides an adequate LUMO offset with the fullerene acceptor for efficient charge separation. The material complies with the RoHS Directive 2011/65/EU exemption 7(c)‑I for brominated flame retardants unintentionally present in electronic components, as bromine originates from the conjugated backbone rather than from additive retardants.

Industrial slimicide and in‑can preservative applications for 2,4‑dibromothiazole exploit its electrophilic interaction with thiol‑containing enzymes central to microbial metabolism. A commercially deployed formulation consists of a 10% w/w solution of the active in 2‑(2‑butoxyethoxy)ethanol, buffered with 0.5% N‑methyldiethanolamine to maintain a working‑solution pH of 7.0–8.0. This concentrate is injected by a ProMinent Sigma/2 diaphragm metering pump—capable of 0.4–4.0 L/h flow control with ±1% setpoint accuracy—into the recirculating white water loop of a paperboard mill, typically at a dosing point downstream of the save‑all clarifier. The target residual concentration of the thiazole in the process water is 5–15 ppm, continuously monitored by an online UV‑photometer (optek TF16‑N, path length 10 mm, 295 nm) and interlocked with the dosing pump to avoid excursions above 25 ppm, above which mild fish toxicity has been observed in whole‑effluent acute LC₅₀ testing according to OECD 203. Minimum inhibitory concentration (MIC) testing following ASTM E2315‑16 yields an MIC₅₀ of 8 mg/L against Pseudomonas aeruginosa ATCC 15442 and 12 mg/L against Enterobacter aerogenes ATCC 13048 after 24 h contact at 35 °C in nutrient broth. The thiazole remains hydrolytically stable for at least 72 h at pH 6.0–8.5 and 40 °C; however, at pH >9.5 the 4‑bromo substituent undergoes hydrolysis to the corresponding thiazolone, with a half‑life of <4 h at 50 °C, so the product is incompatible with highly alkaline lime‑softening circuits. The finished paper and paperboard are subject to migration and extractives testing according to FDA 21 CFR 176.170 (components of paper and paperboard in contact with aqueous and fatty foods), and the overall treatment programme—often blended with a quaternary ammonium biostat for synergistic control—must be registered under the EPA Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) Section 3 for use in the United States. Manufacturing documentation for the formulated product includes a 5‑batch analysis demonstrating active ingredient content within ±5% of label claim and impurity profiling by LC‑MS/MS covering halogenated thiophene analogues below 0.1% each.

When Stoichiometric Imbalance Exceeds 0.3 mol% in High‑Temperature Poly(azole) Synthesis

In the preparation of poly(thiazole‑ether) copolymers targeted for gas‑separation membranes that must operate at temperatures above 200 °C, 2,4‑dibromothiazole serves as the AA‑type dihalide monomer reacting with 4,4′‑(hexafluoroisopropylidene)diphenol (bisphenol AF) under high‑temperature N‑arylation conditions. The copolymerisation follows an AA/BB step‑growth mechanism where the number‑average degree of polymerisation (Xₙ) is governed by the Carothers equation and therefore demands a stoichiometric ratio r = [dibromide]₀/[diphenol]₀ within the range 0.997–1.003 to achieve an Mₙ above 20 kDa. A deviation as small as 0.3 mol% from perfect equimolar balance—equivalent to only 3.0 mmol excess in a 1.0 mol‑scale batch—results in Xₙ dropping below 20, which translates into penetration of the thin‑film composite gutter layer by the selective layer polymer and a loss of CO₂/CH₄ selectivity to virtually unity. The synthesis is conducted in a thoroughly dried, NMP‑based system with K₂CO₃ (1.1 equiv) as base, using a vigorously overhead‑stirred 1 L Parr reactor with a Type 316L thermowell that accommodates a 6‑blade gas‑entrainment impeller. Pre‑drying of the bisphenol monomer under high vacuum (<1 mbar) at 70 °C for 12 h and Karl Fischer titration of the solvent (water content <50 ppm) are imperative because adventitious moisture hydrolyses the 4‑bromo group of the thiazole monomer, generating 4‑hydroxythiazole end‑groups that act as irreversible chain terminators. The reaction profile involves an initial heating ramp to 120 °C for 3 h to build oligomers, followed by a stepwise increase to 180 °C for 6 h to complete the nucleophilic aromatic substitution of the 2‑bromo position, which is approximately 3–5 times more reactive than the 4‑position under these base‑promoted conditions. After polymerisation, the viscous solution is diluted with DMAc, filtered through a 0.45 µm PTFE membrane, and coagulated into methanol. The isolated polymer exhibits a glass‑transition temperature of 245 °C by DSC (second scan, 10 °C/min), a 5% weight‑loss temperature of 415 °C under nitrogen by TGA, and a fractional free volume (FFV) of 0.168 as calculated from density measurements. Dense films cast from a 3 wt% THF solution and dried under a vacuum protocol—24 h at 60 °C, then 12 h at 120 °C in a vacuum oven—yield single‑gas permeabilities directly measured by the constant‑volume/variable‑pressure method (ASTM D1434‑82 (2015)) of 25.2 Barrer for CO₂ and 0.68 Barrer for CH₄, giving an ideal CO₂/CH₄ selectivity of 37.0 at 2 bar feed pressure and 35 °C. The material falls above the 2008 Robeson upper bound for this gas pair, thus confirming the effectiveness of the thiazole unit as a rigid, inter‑chain packing disruptor. Compliance with European chemical legislation requires that the monomer intermediates comply with REACH (EC) 1907/2006 pre‑registration for imported quantities exceeding 1 tonne/year, with full environmental release and persistence assessment done per Chapter R.7b.

Modulating First‑Order Hyperpolarizability through 2,4‑Thiazole‑Based Conjugation Bridges

Nonlinear optical (NLO) chromophores designed for electro‑optic waveguide modulators operating at telecommunications wavelengths (1,310 and 1,550 nm) exploit 2,4‑dibromothiazole as a π‑deficient heterocyclic bridge that connects an electron‑donating diarylamine with a tricyanofuran (TCF) acceptor. The synthetic sequence begins by selectively installing the donor vector at the more electron‑poor 4‑position via a Sonogashira coupling between 2,4‑dibromothiazole (1.0 equiv) and a terminal alkyne derivative of 4‑(N,N‑dibutylamino)benzene (1.05 equiv) utilising PdCl₂(PPh₃)₂ (3 mol%), CuI (6 mol%), and diisopropylethylamine (3.0 equiv) in anhydrous tetrahydropyran at 50 °C for 18 h. The resulting donor‑functionalised 4‑alkynyl‑2‑bromothiazole intermediate is purified by silica gel chromatography (eluent hexane/ethyl acetate 9:1) to remove the homocoupled diyne by‑product. In the second step, the remaining 2‑bromine is converted to an aldehyde by lithium‑halogen exchange using n‑BuLi (1.1 equiv) at ‑78 °C in dry THF, followed by quenching with anhydrous DMF (2.0 equiv), affording the key 4‑alkynylthiazole‑2‑carbaldehyde in 62% yield after aqueous work‑up and Kugelrohr distillation. The TCF acceptor group is attached through a Knoevenagel condensation in a two‑phase system of toluene/acetic acid with ammonium acetate catalyst, producing the final D‑π‑A chromophore as a dark green solid with a melting range of 208–210 °C and λ_max at 687 nm in CHCl₃, as recorded on a Varian Cary 5000 spectrophotometer. When dispersed at 25 wt% in an amorphous polycarbonate (Makrolon 3108) host and poled using a corona discharge at 10 kV with a grid voltage of 500 V at a temperature ramping profile of 5 °C/min from 25 to 145 °C, the guest‑host film exhibits an electro‑optic coefficient r₃₃ of 45 pm/V at 1,550 nm as measured by the attenuated total reflection technique with a SrTiO₃ coupling prism (ATR configuration per IEEE Std 1752‑2017 guidelines). The figure of merit n³r₃₃ is 420 pm/V, sufficient for Mach–Zehnder interferometric modulators requiring a driving voltage VπL of <5 V·cm. The bromine atoms remaining in the chromophore structure are intrinsic to the π‑conjugation tuning and do not degrade the thermal stability: thermogravimetric analysis of the neat chromophore in N₂ atmosphere reveals a decomposition onset (5% weight loss) at 285 °C, compatible with poling temperatures. Regulatory documentation for export of the pre‑poled thin‑film assembly categorises the product under HS code 3907.40, and shipment requires a safety data sheet addressing residual brominated monomer content per UN GHS Revision 9. No special RoHS exemption is needed because the chromophore is not applied as a brominated flame retardant but as an integral component of an optical device.